16-1787682-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012225.4(NUBP2):āc.340A>Gā(p.Ile114Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000769 in 1,612,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012225.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUBP2 | NM_012225.4 | c.340A>G | p.Ile114Val | missense_variant | 4/7 | ENST00000262302.14 | NP_036357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUBP2 | ENST00000262302.14 | c.340A>G | p.Ile114Val | missense_variant | 4/7 | 1 | NM_012225.4 | ENSP00000262302 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152190Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 249990Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135530
GnomAD4 exome AF: 0.0000733 AC: 107AN: 1460168Hom.: 0 Cov.: 30 AF XY: 0.0000785 AC XY: 57AN XY: 726440
GnomAD4 genome AF: 0.000112 AC: 17AN: 152308Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.340A>G (p.I114V) alteration is located in exon 4 (coding exon 4) of the NUBP2 gene. This alteration results from a A to G substitution at nucleotide position 340, causing the isoleucine (I) at amino acid position 114 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at